BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

NonExomics

NonExomics logo

Founded
2021

Technologies

AI Companies (Drug Discovery)

NonExomics apply machine learning technology to discover drugs for diseases arising specifically from non-exom issues. The company integrates all kinds of omics data – genomics, transcriptomics, proteomics – to predict nonexomic proteins and identify disease-causing targets. NonExomics partners with other biopharma organizations to design biomarker assays, identify biomarker candidates, therapeutic targets and drugs.


Posts Mentioning This Company

11 AI-powered Drug Discovery Startups Founded in 2021

  
The community of AI-driven biotech companies is continuously expanding, adding new players to the drug discovery race. In 2021 several dozen companies with AI-fueled platforms were founded, and they successfully continued raising funding and establishing strategic collaborations to expand their pipelines and improve computational capabilities.  In this report, we summarize …
SHARE